Array Biopharma (ARRY) Tops Q3 EPS by 38c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.07 +0.25%
Revenue Growth %: -16.4%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: -16.4%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of $0.37, $0.38 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Endava CFO placed on leave amid accounting probe
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
